EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY-NC-ND 4.0

Amnioinfusion compared with expectant management in oligohydramnios with intact amnions in the second and early third trimesters

Ziling Yang, Jie Yao, Zongzhi Yin, Yuanyuan Yang, Zhaolian Wei iD

Acta Obstetricia et Gynecologica Scandinavica · 2024

DOI: 10.1111/aogs.14888 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Acta Obstetricia et Gynecologica Scandinavica, 2024. Verfasst von Ziling Yang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, The First Affiliated Hospital of Anhui Medical University, Hefei, China. Hauptthemen laut MEDLINE: Oligohydramnios, Pregnancy Trimester, Third, Pregnancy Trimester, Second. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: The National Natural Science Incubation Fund of the First Affiliated Hospital of Anhui Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Treatment of oligohydramnios in the mid‐trimester is challenging, because of the high incidence of adverse perinatal outcomes mainly due to bronchopulmonary dysplasia. Antenatal amnioinfusion has been proposed as a possible treatment for oligohydramnios with intact amnions, but there are few relevant studies. This study aimed to evaluate the effectiveness of transabdominal amnioinfusion in the management of oligohydramnios without fetal lethal malformations in the second and early third trimesters. Material and Methods It is a historical cohort study. A total of 79 patients diagnosed with oligohydramnios at 18–32 weeks gestation were enrolled. In the amnioinfusion group ( n = 39), patients received transabdominal amnioinfusion with the assistance of real‐time ultrasound guidance. In the expectant group ( n = 41), patients were treated with 3000 mL of intravenous isotonic fluids daily. The perioperative complications and perinatal outcomes were analyzed.

Results

Compared with the expectant group, the delivery latency was significantly prolonged, and the rate of cesarean delivery was significantly reduced in the amnioinfusion group ( p < 0.05). Although the rate of intrauterine fetal death was significantly reduced, the incidence of spontaneous miscarriage, premature rupture of membranes (PROMs), and threatened preterm labor were significantly higher in the amnioinfusion group than in the expectant group ( p < 0.05). There was no significant difference in terms of perinatal mortality (28.9% vs. 41.4%, p > 0.05). Multivariate logistic regression revealed that amnioinfusion (odds ratio [OR] 0.162, 95% confidence interval [CI] 0.04–0.61, p = 0.008) and gestational age at diagnosis (OR 0.185, 95% CI 0.04–0.73, p = 0.016) were independently associated with neonatal adverse outcomes. Further subgrouping showed that amnioinfusion significantly reduced the frequency of bronchopulmonary hypoplasia for patients ≤26 weeks (26.7% vs. 75.0%, p = 0.021). The rates of other neonatal complications were similar in both groups.

Conclusions

Amnioinfusion has no significant effect on improving the perinatal mortality of oligohydramnios in the second and early third trimesters. It may lead to a relatively high rate of PROM and spontaneous abortion. However, amnioinfusion may significantly improve the latency period, the rate of cesarean delivery, and neonatal outcomes of oligohydramnios, especially for women ≤26 weeks with high risk of neonatal bronchopulmonary hypoplasia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OligohydramniosPregnancy Trimester, ThirdPregnancy Trimester, SecondHumansFemalePregnancyAdultAmniotic FluidPregnancy OutcomeInfant, NewbornCohort StudiesWatchful WaitingCesarean SectionTreatment OutcomeGestational AgeAmnionUltrasonography, Prenatal

Stichwörter der Autor:innen

amnioinfusionbronchopulmonary dysplasiaoligohydramniospremature rupture of membranes

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
  • NHC Key Laboratory of the Study of Abnormal Gametes and the Reproductive Tract, Anhui Medical University, Hefei, China.

ORCID-Profile: Zhaolian Wei

Förderung

  • The National Natural Science Incubation Fund of the First Affiliated Hospital of Anhui Medical University

Zitieren

APA

Yang, Z., Yao, J., Yin, Z., Yang, Y., & Wei, Z. (2024). Amnioinfusion compared with expectant management in oligohydramnios with intact amnions in the second and early third trimesters. Acta Obstetricia et Gynecologica Scandinavica. https://doi.org/10.1111/aogs.14888

Vancouver

Yang Z, Yao J, Yin Z, Yang Y, Wei Z. Amnioinfusion compared with expectant management in oligohydramnios with intact amnions in the second and early third trimesters. Acta Obstetricia et Gynecologica Scandinavica. 2024. doi:10.1111/aogs.14888

BibTeX
@article{Yang2024,
  author = {Yang, Ziling and Yao, Jie and Yin, Zongzhi and Yang, Yuanyuan and Wei, Zhaolian},
  title = {Amnioinfusion compared with expectant management in oligohydramnios with intact amnions in the second and early third trimesters},
  journal = {Acta Obstetricia et Gynecologica Scandinavica},
  year = {2024},
  doi = {10.1111/aogs.14888}
}
Kostenlos starten →